Nephrocare Health Services: Monitoring Agency Report for IPO Proceeds Q2 FY27

Nephrocare Health Services Ltd has submitted its Monitoring Agency Report for the quarter ended September 30, 2026, as required by SEBI regulations. The report, issued by Crisil Ratings Limited, details the utilization of proceeds from the company's Initial Public Offer (IPO). The IPO, which occurred from December 10-12, 2025, raised ₹3,534.05 million (₹353.41 Crore) in gross proceeds, with net proceeds of ₹3,251.53 million (₹325.15 Crore) after deducting issue expenses of ₹282.52 million (₹28.25 Crore). The report indicates no deviation from the stated objects of the issue. The Audit Committee and Board of Directors have reviewed and taken the report on record. The report is also available on the company's website.